These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1405777)

  • 21. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
    Park JW; Heinzler R; Wirtz JH; Fieten-Rumswinkel M; Braun P; May E; Hetzer R; Heinrich KW
    Z Kardiol; 1994; 83 Suppl 2():49-53. PubMed ID: 8091824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis value of atrial natriuretic peptide and brain natriuretic peptide for heart failure in patients undergoing allogeneic bone marrow transplantation.
    Takatsuka H; Nakajima T; Nomura K; Okikawa Y; Wakae T; Toda A; Itoi H; Okada M; Misawa M; Hara H; Ogawa H
    Hematology; 2006 Oct; 11(5):351-4. PubMed ID: 17607585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction.
    Sato T; Yoshihisa A; Kanno Y; Suzuki S; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Ishida T; Takeishi Y
    Eur J Prev Cardiol; 2017 Dec; 24(18):1979-1987. PubMed ID: 29086584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preanesthetic evaluation of the patient with end-stage heart failure.
    Sumler M; Vadlamudi R
    Best Pract Res Clin Anaesthesiol; 2017 Jun; 31(2):179-188. PubMed ID: 29110791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection and treatment of candidates for heart transplantation.
    Costanzo MR
    Semin Thorac Cardiovasc Surg; 1996 Apr; 8(2):113-25. PubMed ID: 8672564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic assessment of end-stage cardiac failure.
    Vranckx P; Van Cleemput J
    Acta Cardiol; 1998; 53(2):121-5. PubMed ID: 9684036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group.
    Cohn JN; Johnson GR; Shabetai R; Loeb H; Tristani F; Rector T; Smith R; Fletcher R
    Circulation; 1993 Jun; 87(6 Suppl):VI5-16. PubMed ID: 8500240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additive Prognostic Value of Echocardiographic Global Longitudinal and Global Circumferential Strain to Electrocardiographic Criteria in Patients With Heart Failure Undergoing Cardiac Resynchronization Therapy.
    Delgado-Montero A; Tayal B; Goda A; Ryo K; Marek JJ; Sugahara M; Qi Z; Althouse AD; Saba S; Schwartzman D; Gorcsan J
    Circ Cardiovasc Imaging; 2016 Jun; 9(6):. PubMed ID: 27252359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection and management of candidates for heart transplantation.
    Stevenson LW
    Curr Opin Cardiol; 1996 Mar; 11(2):166-73. PubMed ID: 8736688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis of medically treated patients referred for cardiac transplantation.
    Oechslin E; Brunner-LaRocca HP; Solt G; Sütsch G; Jenni R; Gallino A; Mayer K; Vogt P; Künzli A; Turina M; Kiowski W
    Int J Cardiol; 1998 Mar; 64(1):75-81. PubMed ID: 9579819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.
    Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F
    J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study.
    Corrà U; Agostoni P; Giordano A; Cattadori G; Battaia E; La Gioia R; Scardovi AB; Emdin M; Metra M; Sinagra G; Limongelli G; Raimondo R; Re F; Guazzi M; Belardinelli R; Parati G; Magrì D; Fiorentini C; Cicoira M; Salvioni E; Giovannardi M; Veglia F; Mezzani A; Scrutinio D; Di Lenarda A; Ricci R; Apostolo A; Iorio AM; Paolillo S; Palermo P; Contini M; Vassanelli C; Passino C; Giannuzzi P; Piepoli MF; ; ; Antonioli L; Segurini C; Bertella E; Farina S; Bovis F; Pietrucci F; Malfatto G; Roselli T; Buono A; Calabrò R; De Maria R; Santoro D; Campanale S; Caputo D; Bertipaglia D; Berton E
    Int J Cardiol; 2016 Jan; 203():1067-72. PubMed ID: 26638056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of Oxygen Kinetics During Recovery From Cardiopulmonary Exercise Testing in Patients With Chronic Heart Failure.
    Fortin M; Turgeon PY; Nadreau É; Grégoire P; Maltais LG; Sénéchal M; Provencher S; Maltais F
    Can J Cardiol; 2015 Oct; 31(10):1259-65. PubMed ID: 26115872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure.
    Frigerio M; Gronda EG; Mangiavacchi M; Andreuzzi B; Colombo T; De Vita C; Oliva F; Quaini E; Pellegrini A
    J Heart Lung Transplant; 1997 Feb; 16(2):160-8. PubMed ID: 9059927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival.
    Rickenbacher PR; Trindade PT; Haywood GA; Vagelos RH; Schroeder JS; Willson K; Prikazsky L; Fowler MB
    J Am Coll Cardiol; 1996 Apr; 27(5):1192-7. PubMed ID: 8609341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systolic blood pressure influences the interpretation of cardiopulmonary exercise tests and helps identify a very high-risk cohort of heart failure patients.
    Bard RL; Gillespie BW; Lange DC; Pinter A; Nicklas JM
    J Heart Lung Transplant; 2014 Apr; 33(4):388-96. PubMed ID: 24661454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe congestive heart failure. How successful are drug and transplant therapies?
    Yancy CW
    Postgrad Med; 1991 May; 89(6):111-5, 118. PubMed ID: 2020641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure.
    Long EF; Swain GW; Mangi AA
    Circ Heart Fail; 2014 May; 7(3):470-8. PubMed ID: 24563450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiopulmonary Exercise Testing in Aortic Stenosis.
    Le VDT
    Dan Med J; 2017 May; 64(5):. PubMed ID: 28552098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.